{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:34:33Z","timestamp":1775734473643,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jtha.2024.07.031","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T07:40:54Z","timestamp":1726126854000},"page":"3199-3208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-9236","authenticated-orcid":false,"given":"Marie-Charlotte","family":"Bourrienne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Loyau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doroth\u00e9e","family":"Faille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliette","family":"Gay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9l\u00e9na","family":"Akhenak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carine","family":"Farkh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Ollivier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mialitiana","family":"Solonomenjanahary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Choqueux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"Villeval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Plo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Edmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beno\u00eet","family":"Ho-Tin-No\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Ajzenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika\u00ebl","family":"Mazighi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.07.031_bib1","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jtha.2024.07.031_bib2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12885-019-5387-9","article-title":"A\u00a0systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms","volume":"19","author":"Rungjirajittranon","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jtha.2024.07.031_bib3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/hemato2020018","article-title":"Can novel insights into the pathogenesis of myeloproliferative neoplasm-related thrombosis inform novel treatment approaches?","volume":"2","author":"Wolach","year":"2021","journal-title":"Hemato"},{"key":"10.1016\/j.jtha.2024.07.031_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/bjh.18322","article-title":"Practical management of the haemorrhagic complications of myeloproliferative neoplasms","volume":"199","author":"Jones","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.07.031_bib5","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood-2013-10-530832","article-title":"Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm","volume":"124","author":"Lamrani","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.031_bib6","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.1312148111","article-title":"JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms","volume":"111","author":"Etheridge","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.07.031_bib7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/09537104.2020.1742309","article-title":"Use of rotational thromboelastometry for a global screening of coagulation profile in patients of myeloproliferative neoplasms","volume":"32","author":"\u015eahin","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2024.07.031_bib8","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MBC.0000000000000724","article-title":"An evaluation of global coagulation assays in myeloproliferative neoplasm","volume":"29","author":"Lim","year":"2018","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2024.07.031_bib9","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1038\/s41598-017-02498-2","article-title":"Development and validation of a high throughput whole blood thrombolysis plate assay","volume":"7","author":"Bonnard","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2024.07.031_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/jth.14338","article-title":"Increased urokinase and consumption of \u03b12-antiplasmin as an explanation for the loss of benefit of tranexamic acid after treatment delay","volume":"17","author":"Longstaff","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.031_bib11","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-0040-1709526","article-title":"Functional fibrinolysis assays reveal different mechanisms underlying plasminogen dysfunction in ligneous conjunctivitis","volume":"120","author":"Bourrienne","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.031_bib12","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/cancers12040992","article-title":"Interferon alpha therapy increases pro-thrombotic biomarkers in patients with myeloproliferative neoplasms","volume":"12","author":"Faille","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtha.2024.07.031_bib13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/jth.14002","article-title":"An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH","volume":"16","author":"Pieters","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.031_bib14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/jth.13656","article-title":"Development of Shiny app tools to simplify and standardize the analysis of hemostasis assay data: communication from the SSC of the ISTH","volume":"15","author":"Longstaff","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.031_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.thromres.2014.04.025","article-title":"Platelet-related fibrinolysis resistance in patients suffering from PV. Impact of clot retraction and isovolemic erythrocytapheresis","volume":"134","author":"Rusak","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.031_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/ijlh.12688","article-title":"Global assays of fibrinolysis","volume":"39","author":"Ilich","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2024.07.031_bib17","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jtha.2023.01.008","article-title":"Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis","volume":"21","author":"Zheng","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.031_bib18","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1213\/01.ANE.0000149902.73689.64","article-title":"The effects of platelet count on clot retraction and tissue plasminogen activator-induced fibrinolysis on thrombelastography","volume":"100","author":"Katori","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtha.2024.07.031_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.thromres.2023.04.001","article-title":"Increased reactive oxygen species lead to overactivation of platelets in essential thrombocythemia","volume":"226","author":"Dong","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.031_bib20","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1161\/ATVBAHA.111.229088","article-title":"Lytic resistance of fibrin containing red blood cells","volume":"31","author":"Wohner","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.07.031_bib21","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1160\/TH14-08-0669","article-title":"DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment","volume":"113","author":"Varj\u00fa","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.031_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2020.10.014","article-title":"Determinants of plasma fibrin clot lysis measured using three different assays in healthy subjects","volume":"197","author":"Siudut","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.031_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1096-8652(199903)60:3<196::AID-AJH5>3.0.CO;2-G","article-title":"Study of fibrinolytic parameters in different types of polycythemia","volume":"60","author":"Lugassy","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2024.07.031_bib24","first-page":"684","article-title":"Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes","volume":"6","author":"Ro\u015b\u0107","year":"2000","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jtha.2024.07.031_bib25","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.3390\/ijms22052721","article-title":"A\u00a0narrative review on plasminogen activator inhibitor-1 and its (patho)physiological role: to target or not to target?","volume":"22","author":"Sillen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jtha.2024.07.031_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0049-3848(98)00005-X","article-title":"Reduced in\u00a0vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia","volume":"90","author":"P\u00f3s\u00e1n","year":"1998","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.031_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1179\/102453310X12719010991740","article-title":"Treatment related changes in antifibrinolytic activity in patients with polycythemia vera","volume":"15","author":"Sonmez","year":"2010","journal-title":"Hematology"},{"key":"10.1016\/j.jtha.2024.07.031_bib28","first-page":"110","article-title":"Altered plasma fibrin clot properties in essential thrombocythemia","volume":"27","author":"Ma\u0142ecki","year":"2016","journal-title":"Platelets"},{"key":"10.1016\/j.jtha.2024.07.031_bib29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0049-3848(94)90226-7","article-title":"High plasma levels of plasminogen activator inhibitor 1 (PAI-1) in polycythemia vera and essential thrombocythemia are associated with thrombosis","volume":"75","author":"Cancelas","year":"1994","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.031_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1182\/blood-2008-12-196535","article-title":"Src tyrosine kinase preactivation is associated with platelet hypersensitivity in essential thrombocythemia and polycythemia vera","volume":"115","author":"Randi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.07.031_bib31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.thromres.2014.03.042","article-title":"Role of a Janus kinase 2-dependent signaling pathway in platelet activation","volume":"133","author":"Lu","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.031_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.thromres.2018.01.039","article-title":"Endothelial cell functions impaired by interferon in\u00a0vitro: insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy","volume":"163","author":"Jia","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.07.031_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0038-1650230","article-title":"Fibrinolytic response to interferon-alpha in healthy human subjects","volume":"75","author":"Corssmit","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.07.031_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2006.11.001","article-title":"Thrombin generation and fibrin clot structure","volume":"21","author":"Wolberg","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtha.2024.07.031_bib35","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1074\/jbc.M606650200","article-title":"Platelet factor 4 (CXCL4) seals blood clots by altering the structure of fibrin","volume":"282","author":"Amelot","year":"2007","journal-title":"J\u00a0Biol Chem"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624004872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:56:56Z","timestamp":1762030616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624004872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1538783624004872"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.07.031","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired fibrinolysis in JAK2V617F-related myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.07.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}